This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Albireo Pharma
ALBO
A$67.67
Share price
0.00%
Change (1 day)
119.79%
Change (1 year)
Categories
Market capitalization of Albireo Pharma (ALBO)
Last known market cap: A$1.40 Billion
On May 5, 2023 Albireo Pharma had a market cap of A$1.40 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Albireo Pharma from 2007 to 2023
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2023 | A$1.34 B | 104.49% |
| 2022 | A$0.65 B | 6.05% |
| 2021 | A$0.61 B | -33.49% |
| 2020 | A$0.93 B | 101.36% |
| 2019 | A$0.46 B | 11.06% |
| 2018 | A$0.41 B | 42.83% |
| 2017 | A$0.29 B | 88.54% |
| 2016 | A$0.15 B | 413.06% |
| 2015 | A$30.16 M | -20.85% |
| 2014 | A$38.11 M | -29.23% |
| 2013 | A$53.85 M | 68% |
| 2012 | A$32.05 M | 39.21% |
| 2011 | A$23.02 M | -51.64% |
| 2010 | A$47.62 M | -58.73% |
| 2009 | A$0.11 B | -28.77% |
| 2008 | A$0.16 B | -69.94% |
| 2007 | A$0.53 B |
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | A$1.49 B | 6.44% | 🇺🇸 USA |